These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3639088)

  • 1. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
    Webster ME; Guimaraes JA; Kaplan AP; Colman RW; Pierce JV
    Adv Exp Med Biol; 1976; 70(00):285-99. PubMed ID: 937135
    [No Abstract]   [Full Text] [Related]  

  • 12. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C; Musca A; Violi F; Alessandri C; Ferro D; Piromalli A; Balsano F
    Haemostasis; 1984; 14(2):218-22. PubMed ID: 6564063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay methods for prekallikrein and kininogens and their applications.
    Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
    Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).
    Chan JY; Burrowes CE; Movat HZ
    Agents Actions; 1978 Jan; 8(1-2):65-72. PubMed ID: 636957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.